Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVS NYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$148.00-1.2%$151.32$107.96▼$170.46$282.40B0.462.03 million shs829,343 shsXLVHealth Care Select Sector SPDR Fund$145.10-1.0%$147.33$127.96▼$160.59$38.03B0.5812.91 million shs8.93 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis+0.09%+3.03%-2.32%-8.12%+42.47%XLVHealth Care Select Sector SPDR Fund-0.05%+1.32%-1.48%-7.00%+13.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$148.00-1.2%$151.32$107.96▼$170.46$282.40B0.462.03 million shs829,343 shsXLVHealth Care Select Sector SPDR Fund$145.10-1.0%$147.33$127.96▼$160.59$38.03B0.5812.91 million shs8.93 million shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis+0.09%+3.03%-2.32%-8.12%+42.47%XLVHealth Care Select Sector SPDR Fund-0.05%+1.32%-1.48%-7.00%+13.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVSNovartis 2.31Hold$141.20-4.59% DownsideXLVHealth Care Select Sector SPDR Fund 2.75Moderate Buy$145.08-0.02% DownsideCurrent Analyst Ratings BreakdownLatest NVS and XLV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2026NVSNovartis Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (A-) ➝ Buy (B)3/26/2026NVSNovartis Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$143.00 ➝ $170.003/19/2026NVSNovartis Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold3/11/2026NVSNovartis ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$180.002/17/2026NVSNovartis TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVSNovartis$54.53B5.18$10.62 per share13.94$20.40 per share7.25XLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVSNovartis$13.98B$6.9821.2015.062.6324.87%38.82%15.16%7/21/2026 (Estimated)XLVHealth Care Select Sector SPDR FundN/AN/A21.15N/AN/AN/AN/AN/AN/ALatest NVS and XLV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/27/2026Q1 2026NVSNovartis$2.11$1.99-$0.12$1.65$13.44 billion$13.52 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNVSNovartis$3.082.08%+5.28%44.13%N/AXLVHealth Care Select Sector SPDR Fund$2.501.72%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVSNovartis0.960.850.65XLVHealth Care Select Sector SPDR FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVSNovartis13.12%XLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipNVSNovartis0.01%XLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVSNovartis75,2671.91 billion1.91 billionOptionableXLVHealth Care Select Sector SPDR FundN/A262.11 millionN/ANot OptionableNVS and XLV HeadlinesRecent News About These CompaniesWhy the Healthcare Sector Warrants Concentrated ExposureMay 13 at 3:32 PM | etftrends.comEApril Jobs Data Put Focus on These Sector ETFs & StocksMay 13 at 11:02 AM | zacks.comHealth Care Select Sector SPDR Fund (NYSEARCA:XLV) Share Price Crosses Below 200-Day Moving Average - Time to Sell?May 6, 2026 | americanbankingnews.comWeekly ETFs: Eight of 11 sectors record outflows; financial sector leads inflowsMay 5, 2026 | seekingalpha.comHealthcare earnings impress with 86% beat rate, yet sector lags: Earnings ScorecardMay 3, 2026 | seekingalpha.comHealthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026April 29, 2026 | aol.comAHealthcare's Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026April 29, 2026 | 247wallst.comWhen the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth RevisitingApril 25, 2026 | 247wallst.comShould You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?April 20, 2026 | zacks.comWhat Johnson & Johnson Earnings Signal for Healthcare ETFsApril 14, 2026 | etftrends.comEMid-cap healthcare stocks with A grade EPS revisions ahead of earningsApril 10, 2026 | msn.comLikely Sector ETF & Stock Winners From March Jobs ReportApril 6, 2026 | zacks.comHealthcare among laggards in Q1; MRNA and DVA lead gainers while HUM dragsApril 1, 2026 | msn.comConsumer Sentiment Weakens: ETFs That Are Worth a LookApril 1, 2026 | zacks.comWhat Q1 Earnings Could Mean for the S&P 500 Uptrend (XLV)...March 24, 2026 | marketbeat.comStagflation Scare? ETFs May Help Protect Your PortfolioMarch 24, 2026 | zacks.comThe S&P 500's 3 Best-Performing Stocks So Far in 2026 (XLV)...March 17, 2026 | marketbeat.comMiddle East Turmoil and U.S. Debt Surge: ETFs in FocusMarch 16, 2026 | zacks.comTime for Investors to Get Defensive. Sell Staples and Buy Healthcare.February 26, 2026 | barrons.comDo More for Your Core: A Tactical Roadmap for Sector InvestingFebruary 26, 2026 | etftrends.comE3 healthcare mutual funds to consider amid sector strengthFebruary 18, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVS and XLV Company DescriptionsNovartis NYSE:NVS$148.00 -1.77 (-1.18%) Closing price 03:59 PM EasternExtended Trading$146.60 -1.40 (-0.94%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.Health Care Select Sector SPDR Fund NYSEARCA:XLV$145.10 -1.53 (-1.04%) Closing price 04:10 PM EasternExtended Trading$144.74 -0.35 (-0.24%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Viking Sails to All-Time Highs—Fundamentals Signal More to Come YETI Rallies After Earnings Beat and Raised Outlook Aeluma's Post-Earnings Dip Creates a Buying Opportunity Cisco’s Vertical Rally May Still Be in the Early Innings Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs McDonald's Is the Cheapest It’s Been in Years—Does That Make It a Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
